123 related articles for article (PubMed ID: 3036401)
1. Initial assessment of tumor-associated antigen CA-125 in patients with ovarian, cervical, and testicular tumors.
Buamah PK; Cornell C; Skillen AW; Cantwell BM; Harris AL
Clin Chem; 1987 Jul; 33(7):1124-5. PubMed ID: 3036401
[TBL] [Abstract][Full Text] [Related]
2. The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary.
Altaras MM; Goldberg GL; Levin W; Darge L; Bloch B; Smith JA
Gynecol Oncol; 1986 Oct; 25(2):150-9. PubMed ID: 2428701
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated antigen Ca 125 before and during the treatment of ovarian carcinoma.
Kivinen S; Kuoppala T; Leppilampi M; Vuori J; Kauppila A
Obstet Gynecol; 1986 Apr; 67(4):468-72. PubMed ID: 3008051
[TBL] [Abstract][Full Text] [Related]
4. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
Suzuki H; Teshima K; Noda K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
[TBL] [Abstract][Full Text] [Related]
5. The clinical value of serum CA125 levels in ovarian cancer patients receiving platinum therapy.
Fish RG; Shelley MD; Maughan T; Rocker I; Adams M
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):831-5. PubMed ID: 3308479
[TBL] [Abstract][Full Text] [Related]
6. Serum CA 125 in ovarian pathology and its variation in ovarian carcinoma after integrated therapy.
Pansini F; Bellinazzi A; Rainaldi V; Santoiemma M; Lenzi B; Jacobs M; Mollica G; Bagni B
Gynecol Obstet Invest; 1986; 21(1):47-51. PubMed ID: 3005141
[TBL] [Abstract][Full Text] [Related]
7. Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma.
Zanaboni F; Vergadoro F; Presti M; Gallotti P; Lombardi F; Bolis G
Gynecol Oncol; 1987 Sep; 28(1):61-7. PubMed ID: 2443433
[TBL] [Abstract][Full Text] [Related]
8. [Detection of CA-125 antigen (non-mucinous ovarian cancer antigen)-- in serum of patients with gynecological malignancies].
Sakamoto S; Kawana H; Shimizu K; Ishihara T; Ueda K; Usman SM; Uchida S; Kawagoe K; Kihara K; Kubo H
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug; 36(8):1261-2. PubMed ID: 6595322
[No Abstract] [Full Text] [Related]
9. CA-125. Use as a tumor marker with mixed mesodermal tumors of the female genital tract.
Peters WA; Bagley CM; Smith MR
Cancer; 1986 Dec; 58(12):2625-7. PubMed ID: 3022909
[TBL] [Abstract][Full Text] [Related]
10. Germ-cell testicular cancer in adults (first of two parts).
Fraley EE; Lange PH; Kennedy BJ
N Engl J Med; 1979 Dec; 301(25):1370-7. PubMed ID: 91971
[No Abstract] [Full Text] [Related]
11. [Significance of CA 125 antigen levels in patients with ovarian cancer].
Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
[TBL] [Abstract][Full Text] [Related]
12. Alpha-fetoprotein as a marker of embryo-specific differentiations in normal and tumor tissues.
Abelev GI
Transplant Rev; 1974; 20(0):3-37. PubMed ID: 4135841
[No Abstract] [Full Text] [Related]
13. Tumour-associated antigen CA 125 in patients with ovarian cancer.
Heinonen PK; Tontti K; Koivula T; Pystynen P
Br J Obstet Gynaecol; 1985 May; 92(5):528-31. PubMed ID: 3857939
[TBL] [Abstract][Full Text] [Related]
14. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR
Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318
[TBL] [Abstract][Full Text] [Related]
15. Cancer antigen 125, carcinoembryonic antigen, and carbohydrate determinant 19-9 in ovarian tumors.
Motoyama T; Watanabe H; Takeuchi S; Watanabe T; Gotoh S; Okazaki E
Cancer; 1990 Dec; 66(12):2628-35. PubMed ID: 2174304
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
Kimura E; Murae M; Koga R; Odawara Y; Nakabayashi Y; Yokoyama K; Nakata H; Totake T; Ochiai K; Yasuda M
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320
[TBL] [Abstract][Full Text] [Related]
17. Blood group-related antigens in human germ cell tumors.
Motzer RJ; Reuter VE; Cordon-Cardo C; Bosl GJ
Cancer Res; 1988 Sep; 48(18):5342-7. PubMed ID: 3044584
[TBL] [Abstract][Full Text] [Related]
18. Use of CA-125 to predict survival of patients with ovarian carcinoma. North Thames Cooperative Group.
Rustin GJ; Gennings JN; Nelstrop AE; Covarrubias H; Lambert HE; Bagshawe KD
J Clin Oncol; 1989 Nov; 7(11):1667-71. PubMed ID: 2681555
[TBL] [Abstract][Full Text] [Related]
19. The role of cancer antigen 125 (CA 125) in the management of ovarian epithelial carcinomas.
Altaras MM; Goldberg GL; Levin W; Bloch B; Darge L; Smith JA
Gynecol Oncol; 1988 May; 30(1):26-34. PubMed ID: 2452770
[TBL] [Abstract][Full Text] [Related]
20. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
